Gold Price Forecast: XAU/USD defends critical $1850 support, not out of the woods yet
Premium|Take advantage of 60% OFF on your first month.
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
CLAIM OFFER- Gold sees a dead cat bounce before it resumes the sell-off.
- Covid vaccine optimism lifts economic recovery hopes, downs stimulus demand.
- XAU/USD to remain at the mercy of risk sentiment, US dollar dynamics.
Gold (XAU/USD) plunged 5% and hit the lowest in six weeks at $1850 in Monday’s trading. The sell-off ensued after Pfizer Inc hailed the success of its COVID-19 vaccine trial and lifted the global stocks alongside Treasury yields on expectations of solid economic recovery. The American pharma giant said its COVID-19 vaccine, developed with German partner BioNTech SE, was more than 90% effective in preventing infection. The rally in Treasury yields fuelled the demand for the US dollar and weighed heavily on the yellow metal, as markets reassessed the need for additional stimulus from the Fed and Congress.
Gold is attempting a dead cat bounce so far this Tuesday, heading back towards the $1900 mark, as the Treasury yields retrace some of the previous gains and stall the dollar’s advance. The market mood has turned tepid probably on reports that China’s COVID-19 vaccine trial halted in Brazil due to death while the producer Sinovac is investigating the cause of the halt.
Amid a lack of significant macro news from the US docket in the day ahead, the broader market sentiment and dollar’s price action will be closely followed by gold traders. Also, a speech by President-elect Joe Biden, due at 1900 GMT, will remain in focus.
Gold: Short-term technical outlook
Hourly chart
Gold challenges the bearish 21-hourly moving average (HMA) hurdle at $1887 on its road to recovery from multi-week troughs.
The hourly Relative Strength Index (RSI) has edged higher but remains in the bearish zone, suggesting the case for a rebound before the downside resumes.
Recapturing 21-HMA is critical for the bulls, with the next upside resistance seen at the horizontal 200-HMA at $1902.
On the flip side, acceptance below the key support at $1849, September 28 low, could revive the correction from record highs of $2075.
- Gold sees a dead cat bounce before it resumes the sell-off.
- Covid vaccine optimism lifts economic recovery hopes, downs stimulus demand.
- XAU/USD to remain at the mercy of risk sentiment, US dollar dynamics.
Gold (XAU/USD) plunged 5% and hit the lowest in six weeks at $1850 in Monday’s trading. The sell-off ensued after Pfizer Inc hailed the success of its COVID-19 vaccine trial and lifted the global stocks alongside Treasury yields on expectations of solid economic recovery. The American pharma giant said its COVID-19 vaccine, developed with German partner BioNTech SE, was more than 90% effective in preventing infection. The rally in Treasury yields fuelled the demand for the US dollar and weighed heavily on the yellow metal, as markets reassessed the need for additional stimulus from the Fed and Congress.
Gold is attempting a dead cat bounce so far this Tuesday, heading back towards the $1900 mark, as the Treasury yields retrace some of the previous gains and stall the dollar’s advance. The market mood has turned tepid probably on reports that China’s COVID-19 vaccine trial halted in Brazil due to death while the producer Sinovac is investigating the cause of the halt.
Amid a lack of significant macro news from the US docket in the day ahead, the broader market sentiment and dollar’s price action will be closely followed by gold traders. Also, a speech by President-elect Joe Biden, due at 1900 GMT, will remain in focus.
Gold: Short-term technical outlook
Hourly chart
Gold challenges the bearish 21-hourly moving average (HMA) hurdle at $1887 on its road to recovery from multi-week troughs.
The hourly Relative Strength Index (RSI) has edged higher but remains in the bearish zone, suggesting the case for a rebound before the downside resumes.
Recapturing 21-HMA is critical for the bulls, with the next upside resistance seen at the horizontal 200-HMA at $1902.
On the flip side, acceptance below the key support at $1849, September 28 low, could revive the correction from record highs of $2075.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.